Pharma Organisations try to Drive Growth
Emerging markets are predicted to account for a third of global pharmaceutical spend by the end of next year and […]
Tags: Africa, antibiotics, Brazil, BSE Sensex, Business/Finance, CAMBRIDGE CONSULTANTS LIMITED, cancer, China, chronic conditions, chronic respiratory problems, Cipla, CIPLA LIMITED, delegate, diabetes, Director, director of global pharma company, East Asia, Economics, Economy of India, Emerging markets, General Manager, Health/Medical/Pharmaceuticals, healthcare, healthcare innovation, heart disease, hypertension, India, Innovation, insurance coverage, Middle East, mumbai, neurological disorders, pharmaceutical, pharmaceutical organisations, Respiratory infections, russia, Sanjay Bhanushali, Smartphones, South East Asia, Structure, therapeutic applications
IAN & India Innovation Fund Co-invest in Consure Medical, a Medical Devices Startup
Indian Angel Network (IAN) and India Innovation Fund announced today an undisclosed investment in Consure Medical; a Delhi based company […]
Reversible loss of Consciousness
Dr Muralidhar Joshi, Director, Department of Anaesthesia & Pain Management, Kamineni Hospitals Innovations in Anaesthetic Equipment There has been tremendous growth in […]
Achieving Patient Centric Health Services via E-Governance
This paper was received for the eHealth track of eIndia 2010 (https://www.eindia.net.in) held at HICC Hyderabad between August 6 and 8th, 2010. The paper was submitted by Dr. T. L. N. Sarma B.A.M.S., M. D., Vice President, Tatapudi Trust; T. G. K. Vasista, Faculty of Skills Development, King Saud University
eHEALTH Worldforum2011 evolving ideas to transform Healthcare : AUGUST 2011
EDITORIAL Innovations for change POLICY PERSPECTIVE Discovering And Learning By Innovation For The Next GEneration is Todays Motto Dr […]
NIF and ICMR collaborates
City-based National Innovation Foundation-India (NIF) and Indian Council of Medical Research (ICMR) at Delhi signed a memorandum of understanding (MoU) on Thursday.
Medical Device Innovation Initiative
The US Food and Drug Administration (FDA) has proposed a new innovation pathway to serve as a priority review programme to speed up the adoption of breakthrough medical devices.
New National Biotechnology Policy
Lauding the government’s initiative of unveiling a National Biotechnology Policy, industry experts said that it was imperative that this policy was implemented in a time bound manner and that the government ensured that it “walked the talk” if the industry had to reap the benefits of the policy.
